Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
DAOSiN®/ Placebo & ProvokAmin® Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
DGB-01 Supplementation
Blackmores Limited
Fatigue
1 trial -
DPP4
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Dairy based toddler nutrition
United Therapeutics Europe Ltd
Weight Gain
1 trial -
Dapagliflozin
Hospital Authority, Hong Kong
Diabetes Mellitus, Type 2
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial -
Daratumumab
The First People's Hospital of Lianyungang
Antibody-mediated Rejection
1 trial -
Dasatinib
The First People's Hospital of Lianyungang
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1 trial -
Dentoblis
The First People's Hospital of Lianyungang
Gingivitis; Chronic
2 trials -
Depot Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
Deucravacitinib
The First People's Hospital of Lianyungang
Palmoplantar Pustulosis
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Benign Neoplasm of Vocal Fold - Glottis
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchoscopy
1 trial -
Dexmedetomidine
Hospital Authority, Hong Kong
CABG
1 trial -
Dexmedetomidine-Esketamine Combination
The First People's Hospital of Lianyungang
Aged
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Liver Cancer
1 trial -
Diclofenac
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Dietary intervention + Physical Activity + Monitoring
NORTHWEST BIOTHERAPEUTICS INC
Gestational Diabetes
1 trial -
Disitamab Vedotin combined with Zimberelizumab
The First People's Hospital of Lianyungang
Biliary Carcinoma
1 trial -
Dobutamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Patients With Septic Shock
1 trial -
Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
The First People's Hospital of Lianyungang
Diabetes
1 trial -
EAA+W & Carbohydrate
United Therapeutics Europe Ltd
Energy Deficit
1 trial -
EPCs plus PTA
The First People's Hospital of Lianyungang
Diabetic Foot
1 trial -
ERA
NORTHWEST BIOTHERAPEUTICS INC
Infertility, Female
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources